Publications

The Journal of molecular diagnostics : JMD

A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice.

01-01-2023

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer.

01-01-2023

N Engl J Med

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

08-12-2022

Key Publication

The New England journal of medicine

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.

08-12-2022

European journal of cancer (Oxford, England : 1990)

Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer.

01-11-2022

Gynecologic oncology

Clinical implementation of routine diagnostic laparoscopy to guide initial treatment in patients with advanced-stage epithelial ovarian cancer in Dutch clinical practice: Evaluation of support and a budget impact analysis.

01-06-2022

Scientific reports

Cost-utility analysis on robot-assisted and laparoscopic prostatectomy based on long-term functional outcomes.

10-05-2022

BMC cancer

Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness.

06-05-2022

Cancers

Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance.

31-03-2022

BMC medical research methodology

Developing a dynamic simulation model to support the nationwide implementation of whole genome sequencing in lung cancer.

27-03-2022

International journal of health policy and management

Understanding the Costs of Surgery: A Bottom-Up Cost Analysis of Both a Hybrid Operating Room and Conventional Operating Room.

01-03-2022

Nederlands tijdschrift voor geneeskunde

[Clinical efficiency research with expensive drugs: doing more with less investment].

15-02-2022

Cancer discovery

Improving the Affordability of Anticancer Medicines Demands Evidence-Based Policy Solutions.

01-02-2022

Cancer research communications

Affordable Prices Without Threatening the Oncological R&D Pipeline-An Economic Experiment on Transparency in Price Negotiations.

01-01-2022

PharmacoEconomics

Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer.

01-12-2021

BMC public health

Supporting participation in paid work of cancer survivors and their partners in the Netherlands: protocol of the SusTained Employability in cancer Patients and their partnerS (STEPS) multi-centre randomized controlled trial and cohort study.

12-10-2021

Annals of oncology : official journal of the European Society for Medical Oncology

A revolving research fund to study efficient use of expensive drugs: big wheels keep on turning.

01-10-2021

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Long-term functional outcomes after robot-assisted prostatectomy compared to laparoscopic prostatectomy: Results from a national retrospective cluster study.

01-10-2021

Cancers

Preferences of Treatment Strategies among Women with Low-Risk DCIS and Oncologists.

06-08-2021

Medical decision making : an international journal of the Society for Medical Decision Making

Modeling Diagnostic Strategies to Manage Toxic Adverse Events following Cancer Immunotherapy.

01-08-2021

Cancers

Effects of and Lessons Learned from an Internet-Based Physical Activity Support Program (with and without Physiotherapist Telephone Counselling) on Physical Activity Levels of Breast and Prostate Cancer Survivors: The PABLO Randomized Controlled Trial.

21-07-2021

Expert review of pharmacoeconomics & outcomes research

Early technology assessment of using whole genome sequencing in personalized oncology.

01-06-2021

Expert review of pharmacoeconomics & outcomes research

Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing.

01-06-2021

Breast cancer research and treatment

Treating (low-risk) DCIS patients: What can we learn from real-world cancer registry evidence?

01-05-2021

BMC cancer

Whole genome sequencing in oncology: using scenario drafting to explore future developments.

01-05-2021

BMC cancer

Dedicated MRI staging versus surgical staging of peritoneal metastases in colorectal cancer patients considered for CRS-HIPEC; the DISCO randomized multicenter trial.

26-04-2021

The Journal of molecular diagnostics : JMD

Real-World Utilization of Biomarker Testing for Patients with Advanced Non-Small Cell Lung Cancer in a Tertiary Referral Center and Referring Hospitals.

01-04-2021

Journal of cancer policy

Securing sustainable price levels of innovative anticancer drugs: How to move forward?

01-03-2021

The Laryngoscope

Cost-Effectiveness of Surgery Versus Organ Preservation in Advanced Laryngeal Cancer.

01-02-2021

The Journal of surgical research

Selecting Image-Guided Surgical Technologies in Oncology: A Surgeon's Perspective.

01-01-2021

Head & neck

Cost-effectiveness analysis of using the heat and moisture exchangers compared with alternative stoma covers in laryngectomy rehabilitation: US perspective.

01-12-2020

BMC medical genomics

Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE).

10-11-2020

Critical reviews in oncology/hematology

Observed versus modelled lifetime overall survival of targeted therapies and immunotherapies for advanced non-small cell lung cancer patients - A systematic review.

01-09-2020

European journal of cancer (Oxford, England : 1990)

Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trial.

01-09-2020

BMC cancer

Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness.

31-07-2020

BMC cancer

Design of the PROstate cancer follow-up care in Secondary and Primary hEalth Care study (PROSPEC): a randomized controlled trial to evaluate the effectiveness of primary care-based follow-up of localized prostate cancer survivors.

08-07-2020

JAMA oncology

Evidence Underlying Policy Proposals for Sustainable Anticancer Drug Prices: A Systematic Review.

01-06-2020

PloS one

Early budget impact analysis on magnetic seed localization for non-palpable breast cancer surgery.

14-05-2020

Cancers

The Validity and Predictive Value of Blood-Based Biomarkers in Prediction of Response in the Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review.

30-04-2020

Trials

GERiatric Screening in the treatment of elderly patients with Ovarian Carcinoma (GERSOC): study protocol for a pragmatic, cluster randomised controlled trial.

22-02-2020

European journal of medical genetics

Experts reflecting on the duty to recontact patients and research participants; why professionals should take the lead in developing guidelines.

01-02-2020

PloS one

Mapping the EORTC QLQ-C30 and QLQ-H&N35 to the EQ-5D for head and neck cancer: Can disease-specific utilities be obtained?

14-12-2019

Breast cancer research and treatment

Cost-utility, cost-effectiveness, and budget impact of Internet-based cognitive behavioral therapy for breast cancer survivors with treatment-induced menopausal symptoms.

01-12-2019

Health policy (Amsterdam, Netherlands)

Barriers and facilitators of patient access to medical devices in Europe: A systematic literature review.

01-12-2019

Drug discovery today

Impact of organ-on-a-chip technology on pharmaceutical R&D costs.

01-09-2019

BMC medical informatics and decision making

The impact of an online patient decision aid for women with breast cancer considering immediate breast reconstruction: study protocol of a multicenter randomized controlled trial.

19-08-2019

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial.

10-08-2019

Lung cancer (Amsterdam, Netherlands)

Variation in the time to treatment for stage III and IV non-small cell lung cancer patients for hospitals in the Netherlands.

01-08-2019

BMC cancer

Study protocol of a prospective multicenter study comparing (cost-)effectiveness of a tailored interdisciplinary head and neck rehabilitation program to usual supportive care for patients treated with concomitant chemo- or bioradiotherapy.

03-07-2019

BMC cancer

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).

06-05-2019

A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice.

Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer.

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.

Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer.

Clinical implementation of routine diagnostic laparoscopy to guide initial treatment in patients with advanced-stage epithelial ovarian cancer in Dutch clinical practice: Evaluation of support and a budget impact analysis.

Cost-utility analysis on robot-assisted and laparoscopic prostatectomy based on long-term functional outcomes.

Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness.

Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance.

Developing a dynamic simulation model to support the nationwide implementation of whole genome sequencing in lung cancer.

Understanding the Costs of Surgery: A Bottom-Up Cost Analysis of Both a Hybrid Operating Room and Conventional Operating Room.

[Clinical efficiency research with expensive drugs: doing more with less investment].

Improving the Affordability of Anticancer Medicines Demands Evidence-Based Policy Solutions.

Affordable Prices Without Threatening the Oncological R&D Pipeline-An Economic Experiment on Transparency in Price Negotiations.

Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer.

Supporting participation in paid work of cancer survivors and their partners in the Netherlands: protocol of the SusTained Employability in cancer Patients and their partnerS (STEPS) multi-centre randomized controlled trial and cohort study.

A revolving research fund to study efficient use of expensive drugs: big wheels keep on turning.

Long-term functional outcomes after robot-assisted prostatectomy compared to laparoscopic prostatectomy: Results from a national retrospective cluster study.

Preferences of Treatment Strategies among Women with Low-Risk DCIS and Oncologists.

Modeling Diagnostic Strategies to Manage Toxic Adverse Events following Cancer Immunotherapy.

Effects of and Lessons Learned from an Internet-Based Physical Activity Support Program (with and without Physiotherapist Telephone Counselling) on Physical Activity Levels of Breast and Prostate Cancer Survivors: The PABLO Randomized Controlled Trial.

Early technology assessment of using whole genome sequencing in personalized oncology.

Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing.

Treating (low-risk) DCIS patients: What can we learn from real-world cancer registry evidence?

Whole genome sequencing in oncology: using scenario drafting to explore future developments.

Dedicated MRI staging versus surgical staging of peritoneal metastases in colorectal cancer patients considered for CRS-HIPEC; the DISCO randomized multicenter trial.

Real-World Utilization of Biomarker Testing for Patients with Advanced Non-Small Cell Lung Cancer in a Tertiary Referral Center and Referring Hospitals.

Securing sustainable price levels of innovative anticancer drugs: How to move forward?

Cost-Effectiveness of Surgery Versus Organ Preservation in Advanced Laryngeal Cancer.

Selecting Image-Guided Surgical Technologies in Oncology: A Surgeon's Perspective.

Cost-effectiveness analysis of using the heat and moisture exchangers compared with alternative stoma covers in laryngectomy rehabilitation: US perspective.

Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE).

Observed versus modelled lifetime overall survival of targeted therapies and immunotherapies for advanced non-small cell lung cancer patients - A systematic review.

Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trial.

Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness.

Design of the PROstate cancer follow-up care in Secondary and Primary hEalth Care study (PROSPEC): a randomized controlled trial to evaluate the effectiveness of primary care-based follow-up of localized prostate cancer survivors.

Evidence Underlying Policy Proposals for Sustainable Anticancer Drug Prices: A Systematic Review.

Early budget impact analysis on magnetic seed localization for non-palpable breast cancer surgery.

The Validity and Predictive Value of Blood-Based Biomarkers in Prediction of Response in the Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review.

GERiatric Screening in the treatment of elderly patients with Ovarian Carcinoma (GERSOC): study protocol for a pragmatic, cluster randomised controlled trial.

Experts reflecting on the duty to recontact patients and research participants; why professionals should take the lead in developing guidelines.

Mapping the EORTC QLQ-C30 and QLQ-H&N35 to the EQ-5D for head and neck cancer: Can disease-specific utilities be obtained?

Cost-utility, cost-effectiveness, and budget impact of Internet-based cognitive behavioral therapy for breast cancer survivors with treatment-induced menopausal symptoms.

Barriers and facilitators of patient access to medical devices in Europe: A systematic literature review.

Impact of organ-on-a-chip technology on pharmaceutical R&D costs.

The impact of an online patient decision aid for women with breast cancer considering immediate breast reconstruction: study protocol of a multicenter randomized controlled trial.

Cost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial.

Variation in the time to treatment for stage III and IV non-small cell lung cancer patients for hospitals in the Netherlands.

Study protocol of a prospective multicenter study comparing (cost-)effectiveness of a tailored interdisciplinary head and neck rehabilitation program to usual supportive care for patients treated with concomitant chemo- or bioradiotherapy.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).

This site uses cookies